+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
FEMALE
ID04113447

Study on Development of Children Conceived Using Mitochondrial Donation with 18-Month Bayley-III Assessment

Led by Newcastle-upon-Tyne Hospitals NHS Trust · Updated on 2025-07-20

25

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to observe the development of children conceived using Mitochondrial Donation MD, focusing on fetal and postnatal growth. Researchers will assess neurodevelopmental outcomes at 18 months corrected age using the internationally recognized Bayley-III developmental tool. The study tests the hypothesis that children born through MD IVF techniques show normal neurodevelopment at this age. The study involves monitoring children conceived via Mitochondrial Donation without any treatment intervention, as it is observational. Developmental assessments including the Bayley-III are scheduled at 18 months corrected age. Additional evaluations for normal hearing and vision by audiologists and ophthalmologists are also conducted at the same time point. Participants will be followed from pregnancy through delivery until the child reaches 18 months corrected age. Data on pregnancy, delivery, and child development will be collected and reviewed. The primary outcome is the neurodevelopmental score at 18 months, with secondary outcomes including hearing and vision status. The study provides a comprehensive developmental overview over this period, with no active treatment administered.

CONDITIONS

Brief Title

Mitochondrial Donation: An 18 Month Outcome Study.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here